OrbiMed Advisors LLC and OrbiMed Capital GP V LLC Sell 1 Million Shares of PMV Pharmaceuticals

On October 23, 2025, OrbiMed Advisors LLC and OrbiMed Capital GP V LLC, both ten percent owners of PMV Pharmaceuticals, Inc., sold 1,000,000 shares of common stock at a price of $1.52 per share. Following the transaction, the entities collectively own 4,975,291 shares. The securities are held by OrbiMed Private Investments V, LP, with OrbiMed Capital GP V LLC as its general partner and OrbiMed Advisors LLC as the managing member. Both entities disclaim beneficial ownership of the shares except to the extent of their pecuniary interest. The transaction was reported on Form 4 and signed by Carl L. Gordon, a member of OrbiMed Advisors LLC and the managing member of OrbiMed Capital GP V LLC.